FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Frans Corstens

Research Profile

Chemicals & Drugs

Concepts & Ideas

Tissue Distribution

Procedures

Living Beings

Disorders

Co-author Network

Publications

TOP 3
Marc D Zuijdwijk; Wouter V Vogel; Frans H M Corstens; Wim J G Oyen
Utility of fluorodeoxyglucose-PET in patients with differentiated thyroid carcinoma.
Eric P Visser; Mariëlle E P Philippens; Laura Kienhorst; Johannes H A M Kaanders; Frans H M Corstens; Lioe-Fee de Geus-Oei; Wim J G Oyen
Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Lioe-Fee de Geus-Oei; Henricus F M van der Heijden; Frans H M Corstens; Wim J G Oyen
Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Frans Corstens (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Marc D Zuijdwijk; Wouter V Vogel; Frans H M Corstens; Wim J G Oyen
Utility of fluorodeoxyglucose-PET in patients with differentiated thyroid carcinoma.
Nuclear medicine communications 2008;29(7):636-41.
2008: Eric P Visser; Mariëlle E P Philippens; Laura Kienhorst; Johannes H A M Kaanders; Frans H M Corstens; Lioe-Fee de Geus-Oei; Wim J G Oyen
Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(6):892-8.
2007: Lioe-Fee de Geus-Oei; Henricus F M van der Heijden; Frans H M Corstens; Wim J G Oyen
Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review.
Cancer 2007;110(8):1654-64.
2007: Lioe-Fee de Geus-Oei; Henricus F M van der Heijden; Eric P Visser; Rick Hermsen; Bas A van Hoorn; Johanna N H Timmer-Bonte; Antoon T Willemsen; Jan Pruim; Frans H M Corstens; Paul Krabbe; Wim J G Oyen
Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(10):1592-8.
2007: Ingrid Dijkgraaf; Otto Boerman; Wim J G Oyen; Frans H M Corstens; Martin Gotthardt
Development and application of peptide-based radiopharmaceuticals.
Anti-cancer agents in medicinal chemistry 2007;7(5):543-51.
2007: Huub J J M Rennen; Peter Laverman; Julliëtte E M van Eerd; Wim J G Oyen; Frans H M Corstens; Otto Boerman
PET imaging of infection with a HYNIC-conjugated LTB4 antagonist labeled with F-18 via hydrazone formation.
Nuclear medicine and biology 2007;34(6):691-5.
2007: Wouter V Vogel; Jorn A van Dalen; Bastiaan Wiering; Henkjan J Huisman; Frans H M Corstens; T J M Ruers; Wim J G Oyen
Evaluation of image registration in PET/CT of the liver and recommendations for optimized imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(6):910-9.
2007: Otto Boerman; Manuel J Koppe; Ernst J Postema; Frans H M Corstens; Wim J G Oyen
Radionuclide therapy of cancer with radiolabeled antibodies.
Anti-cancer agents in medicinal chemistry 2007;7(3):335-43.
2007: Chantal P Bleeker-Rovers; Fidel J Vos; Aart H Mudde; Anton S M Dofferhoff; Lioe-Fee de Geus-Oei; Anton J Rijnders; Paul Krabbe; Frans H M Corstens; Jos W M van der Meer; Wim J G Oyen
A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin.
European journal of nuclear medicine and molecular imaging 2007;34(5):694-703.
2007: Ingrid Dijkgraaf; Anneloes Y Rijnders; Annemieke C Soede; Annemarie C Dechesne; G Wilma van Esse; Arwin J Brouwer; Frans H M Corstens; Otto Boerman; Dirk T S Rijkers; Rob M J Liskamp
Synthesis of DOTA-conjugated multivalent cyclic-RGD peptide dendrimers via 1,3-dipolar cycloaddition and their biological evaluation: implications for tumor targeting and tumor imaging purposes.
Organic & biomolecular chemistry 2007;5(6):935-44.
2007: Jorn A van Dalen; Eric P Visser; Wouter V Vogel; Frans H M Corstens; Wim J G Oyen
Impact of Ge-68/Ga-68-based versus CT-based attenuation correction on PET.
Medical physics 2007;34(3):889-97.
2007: Chantal P Bleeker-Rovers; Huub J J M Rennen; Otto Boerman; Ate B Wymenga; Eric P Visser; Johannes H Bakker; Jos W M van der Meer; Frans H M Corstens; Wim J G Oyen
99mTc-labeled interleukin 8 for the scintigraphic detection of infection and inflammation: first clinical evaluation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(3):337-43.
2007: Eric P Visser; Ernst J Postema; Otto Boerman; Jeroen Visschers; Wim J G Oyen; Frans H M Corstens
Software package for integrated data processing for internal dose assessment in nuclear medicine (SPRIND).
European journal of nuclear medicine and molecular imaging 2007;34(3):413-21.
2007: Ingrid Dijkgraaf; John A W Kruijtzer; Cathelijne Frielink; Frans H M Corstens; Wim J G Oyen; Rob M J Liskamp; Otto Boerman
Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide.
International journal of cancer. Journal international du cancer 2007;120(3):605-10.
2007: Ingrid Dijkgraaf; John A W Kruijtzer; Shuang Liu; Annemieke C Soede; Wim J G Oyen; Frans H M Corstens; Rob M J Liskamp; Otto Boerman
Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides.
European journal of nuclear medicine and molecular imaging 2007;34(2):267-73.
2007: Martin Gotthardt; S Bröker; Anja Schlieck; Artur Bauhofer; B Herbst; Martin Béhé; Frans H M Corstens; Thomas M Behr; C Görg
Scintigraphy with 99mTc-labeled heat-altered erythrocytes in diagnosing hyposplenia: prospective comparison to 99mTc-labeled colloids and colour-coded duplex ultrasonography.
Nuklearmedizin. Nuclear medicine 2007;46(4):135-40.
2007: Jorn A van Dalen; Wouter V Vogel; Frans H M Corstens; Wim J G Oyen
Multi-modality nuclear medicine imaging: artefacts, pitfalls and recommendations.
Cancer imaging : the official publication of the International Cancer Imaging Society 2007;7():77-83.
2007: Ingrid Dijkgraaf; Shuang Liu; John A W Kruijtzer; Annemieke C Soede; Wim J G Oyen; Rob M J Liskamp; Frans H M Corstens; Otto Boerman
Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide.
Nuclear medicine and biology 2007;34(1):29-35.
2006: Ingrid Dijkgraaf; John A W Kruijtzer; Cathelijne Frielink; Annemieke C Soede; Hans W Hilbers; Wim J G Oyen; Frans H M Corstens; Rob M J Liskamp; Otto Boerman
Synthesis and biological evaluation of potent alphavbeta3-integrin receptor antagonists.
Nuclear medicine and biology 2006;33(8):953-61.
2006: Julliëtte E M van Eerd; Lioe-Fee de Geus-Oei; Wim J G Oyen; Frans H M Corstens; Otto Boerman
Scintigraphic imaging of P-glycoprotein expression with a radiolabelled antibody.
European journal of nuclear medicine and molecular imaging 2006;33(11):1266-72.
2006: Jorine H Savonije; Cees J van Groeningen; W J M van den Broek; M E M Rentinck; Frans H M Corstens; Chad Gundy; Giuseppe Giaccone; Joannes Marx
Iron absorption during epoetin alfa therapy for chemotherapy-associated anaemia.
Cancer investigation 2006;24(6):562-6.
2006: Lioe-Fee de Geus-Oei; Johannes H A M Kaanders; Lucas A M Pop; Frans H M Corstens; Wim J G Oyen
Effects of hyperoxygenation on FDG-uptake in head-and-neck cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(1):51-6.
2006: Baudewijn W Hendrickx; Cees J A Punt; Otto Boerman; Ernst J Postema; Egbert Oosterwijk; Agapi Mavridu; Frans H M Corstens; Wim J G Oyen
Targeting of biliary cancer with radiolabeled chimeric monoclonal antibody CG250.
Cancer biotherapy & radiopharmaceuticals 2006;21(3):263-8.
2006: Fidel J Vos; Chantal P Bleeker-Rovers; Frans H M Corstens; Bart Jan Kullberg; Wim J G Oyen
FDG-PET for imaging of non-osseous infection and inflammation.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2006;50(2):121-30.
2006: Lioe-Fee de Geus-Oei; Eric P Visser; Paul Krabbe; Bas A van Hoorn; Emile B Koenders; Antoon T Willemsen; Jan Pruim; Frans H M Corstens; Wim J G Oyen
Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(6):945-9.
2006: Wouter V Vogel; Jorn A van Dalen; Dominic A X Schinagl; Johannes H A M Kaanders; Henkjan J Huisman; Frans H M Corstens; Wim J G Oyen
Correction of an image size difference between positron emission tomography (PET) and computed tomography (CT) improves image fusion of dedicated PET and CT.
Nuclear medicine communications 2006;27(6):515-9.
2006: Lioe-Fee de Geus-Oei; G F F M Pieters; Johannes J Bonenkamp; Aart H Mudde; Chantal P Bleeker-Rovers; Frans H M Corstens; Wim J G Oyen
18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(5):770-5.
2006: Julliëtte E M van Eerd; Erik Vegt; Jack F M Wetzels; Frans G M Russel; Rosalinde Masereeuw; Frans H M Corstens; Wim J G Oyen; Otto Boerman
Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(3):528-33.
2006: Erik Vegt; Jack F M Wetzels; Frans G M Russel; Rosalinde Masereeuw; Otto Boerman; Julliëtte E M van Eerd; Frans H M Corstens; Wim J G Oyen
Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(3):432-6.
2006: Lioe-Fee de Geus-Oei; T J M Ruers; Cornelis J A Punt; Jan Willem Leer; Frans H M Corstens; Wim J G Oyen
FDG-PET in colorectal cancer.
Cancer imaging : the official publication of the International Cancer Imaging Society 2006;6():S71-81.
2006: Martin Gotthardt; C Rubner; Artur Bauhofer; F Berce; Wim J G Oyen; J Goecke; Andreas Pfestroff; Anja Schlieck; Frans H M Corstens; Martin Béhé; Thomas M Behr
What is the best pre-therapeutic dosimetry for successful radioiodine therapy of multifocal autonomy?
Nuklearmedizin. Nuclear medicine 2006;45(5):206-12.
2006: Martin Gotthardt; M Stübinger; J Pansegrau; B Buchwald; J Goecke; Andreas Pfestroff; Frans H M Corstens; Thomas M Behr
Decrease of (99m)Tc-uptake in autonomous thyroid tissue in Germany since the 1970s. Clinical implications for radioiodine therapy.
Nuklearmedizin. Nuclear medicine 2006;45(3):122-5.
2005: Chantal P Bleeker-Rovers; Fidel J Vos; Geert J A Wanten; Jos W M van der Meer; Frans H M Corstens; Bart Jan Kullberg; Wim J G Oyen
18F-FDG PET in detecting metastatic infectious disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(12):2014-9.
2005: Matthias Broekema; Julliëtte J E M van Eerd; Wim J G Oyen; Frans H M Corstens; Rob M J Liskamp; Otto Boerman; Thomas D Harris
Synthesis of leukotriene B4 antagonists labeled with In-111 or Tc-99m to image infectious and inflammatory foci.
Journal of medicinal chemistry 2005;48(20):6442-53.
2005: Adrienne H Brouwers; Wilhelmina C A M Buijs; Peter F A Mulders; P H M De Mulder; Wim J M van den Broek; Carola Mala; Egbert Oosterwijk; Otto Boerman; Frans H M Corstens; Wim J G Oyen
Radioimmunotherapy with [131I]cG250 in patients with metastasized renal cell cancer: dosimetric analysis and immunologic response.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7178s-7186s.
2005: Frank G van Schaijk; Egbert Oosterwijk; Annemieke C Soede; Matthias Broekema; Cathelijne Frielink; William J McBride; David M Goldenberg; Frans H M Corstens; Otto Boerman
Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7130s-7136s.
2005: Adrienne H Brouwers; Peter F A Mulders; P H M De Mulder; Wim J M van den Broek; Wilhelmina C A M Buijs; Carola Mala; Frank B M Joosten; Egbert Oosterwijk; Otto Boerman; Frans H M Corstens; Wim J G Oyen
Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6540-8.
2005: Julliëtte E M van Eerd; Matthias Broekema; Thomas D Harris; D Scott Edwards; Wim J G Oyen; Frans H M Corstens; Otto Boerman
Imaging of infection and inflammation with an improved 99mTc-labeled LTB4 antagonist.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(9):1546-51.
2005: Frank G van Schaijk; Otto Boerman; Annemieke C Soede; William J McBride; David M Goldenberg; Frans H M Corstens; Egbert Oosterwijk
Comparison of IgG and F(ab')2 fragments of bispecific anti-RCCxanti-DTIn-1 antibody for pretargeting purposes.
European journal of nuclear medicine and molecular imaging 2005;32(9):1089-95.
2005: Peter J M Kok; Julliëtte E M van Eerd; Otto Boerman; Frans H M Corstens; Wim J G Oyen
Biodistribution and imaging of FDG in rats with LS174T carcinoma xenografts and focal Escherichia coli infection.
Cancer biotherapy & radiopharmaceuticals 2005;20(3):310-5.
2005: Frank G van Schaijk; Matthias Broekema; Egbert Oosterwijk; Julliëtte E M van Eerd; Bill J McBride; David M Goldenberg; Frans H M Corstens; Otto Boerman
Residualizing iodine markedly improved tumor targeting using bispecific antibody-based pretargeting.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(6):1016-22.
2005: Chantal P Bleeker-Rovers; Adilia Warris; Joost P H Drenth; Frans H M Corstens; Wim J G Oyen; Bart Jan Kullberg
Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2005;11(6):493-5.
2005: Julliëtte E M van Eerd; Wim J G Oyen; Thomas D Harris; Huub J J M Rennen; D Scott Edwards; Frans H M Corstens; Otto Boerman
Scintigraphic imaging of infectious foci with an 111In-LTB4 antagonist is based on in vivo labeling of granulocytes.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(5):786-93.
2005: Frank G van Schaijk; Egbert Oosterwijk; Janneke D Molkenboer-Kuenen; Annemieke C Soede; Bill J McBride; David M Goldenberg; Wim J G Oyen; Frans H M Corstens; Otto Boerman
Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(3):495-501.
2005: Wim J G Oyen; Frans H M Corstens; Otto Boerman
Discriminating infection from sterile inflammation: can radiolabelled antibiotics solve the problem?
European journal of nuclear medicine and molecular imaging 2005;32(2):151-2.
2005: Wouter V Vogel; Bastiaan Wiering; Frans H M Corstens; T J M Ruers; Wim J G Oyen
Colorectal cancer: the role of PET/CT in recurrence.
Cancer imaging : the official publication of the International Cancer Imaging Society 2005;5 Spec No A():S143-9.
2005: Michel de Groot; Antoi P W Meeuwis; Peter J M Kok; Frans H M Corstens; Wim J G Oyen
Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut.
European journal of nuclear medicine and molecular imaging 2005;32(1):98-101.
2004: Chantal P Bleeker-Rovers; Andre J A M van der Ven; Bert Zomer; Lioe-Fee de Geus-Oei; Paul Smits; Frans H M Corstens; Peter P Koopmans; Wim J G Oyen
F-18-fluorodeoxyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients.
AIDS (London, England) 2004;18(18):2430-2.
2004: Huub J J M Rennen; Chantal P Bleeker-Rovers; Julliëtte E M van Eerd; Cathelijne Frielink; Wim J G Oyen; Frans H M Corstens; Otto Boerman
99mTc-labeled interleukin-8 for scintigraphic detection of pulmonary infections.
Chest 2004;126(6):1954-61.
2004: Julliëtte E M van Eerd; Huub J J M Rennen; Wim J G Oyen; Thomas D Harris; D Scott Edwards; Frans H M Corstens; Otto Boerman
Scintigraphic detection of pulmonary aspergillosis in rabbits with a radiolabeled leukotriene b4 antagonist.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(10):1747-53.
2004: Chantal P Bleeker-Rovers; Frans H M Corstens; Jos W M van der Meer; Wim J G Oyen
Fever of unknown origin: prospective comparison of diagnostic value of (18)F-FDG PET and (111)In-granulocyte scintigraphy.
European journal of nuclear medicine and molecular imaging 2004;31(9):1342-3; author reply 1344.
2004: Adrienne H Brouwers; Peter F A Mulders; Egbert Oosterwijk; Wilhelmina C A M Buijs; Frans H M Corstens; Otto Boerman; Wim J G Oyen
Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
Cancer biotherapy & radiopharmaceuticals 2004;19(4):466-77.
2004: Lioe-Fee de Geus-Oei; Julliëtte van Eerd-Vismale; Carla F M Molthoff; Frans H M Corstens; Wim J G Oyen; Otto Boerman
Tracers to monitor the response to chemotherapy: in vitro screening of four radiopharmaceuticals.
Cancer biotherapy & radiopharmaceuticals 2004;19(4):457-65.
2004: Marcel Janssen; Cathelijne Frielink; Ingrid Dijkgraaf; Wim J G Oyen; D Scott Edwards; Shuang Liu; Milind Rajopadhye; L F A G Massuger; Frans H M Corstens; Otto Boerman
Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionation.
Cancer biotherapy & radiopharmaceuticals 2004;19(4):399-404.
2004: Wim J G Oyen; Johan Bussink; Ad F T M Verhagen; Frans H M Corstens; Gerben P Bootsma
Role of FDG-PET in the diagnosis and management of lung cancer.
Expert review of anticancer therapy 2004;4(4):561-7.
2004: Cornelis G ter Meulen; Iza van Riemsdijk; Ronald J Hené; Maarten H L Christiaans; George F Borm; Frans H M Corstens; Teun van Gelder; Luuk B Hilbrands; Willem Weimar; Andries J Hoitsma
No important influence of limited steroid exposure on bone mass during the first year after renal transplantation: a prospective, randomized, multicenter study.
Transplantation 2004;78(1):101-6.
2004: Huub J J M Rennen; Cathelijne Frielink; Ernst Brandt; Sebastian A J Zaat; Otto Boerman; Wim J G Oyen; Frans H M Corstens
Relationship between neutrophil-binding affinity and suitability for infection imaging: comparison of (99m)Tc-labeled NAP-2 (CXCL-7) and 3 C-terminally truncated isoforms.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(7):1217-23.
2004: Peter Laverman; Martin Béhé; Wim J G Oyen; Peter H G M Willems; Frans H M Corstens; Thomas M Behr; Otto Boerman
Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors.
Bioconjugate chemistry 2004;15(3):561-8.
2004: Ad F T M Verhagen; Gerben P Bootsma; Vivianne C G Tjan-Heijnen; Gert Jan van der Wilt; A L Cox; M H J Brouwer; Frans H M Corstens; Wim J G Oyen
FDG-PET in staging lung cancer: how does it change the algorithm?
Lung cancer (Amsterdam, Netherlands) 2004;44(2):175-81.
2004: Adrienne H Brouwers; Iris Verel; Julliëtte E M van Eerd; Gerard Visser; Martijn Steffens; Egbert Oosterwijk; Frans H M Corstens; Wim J G Oyen; Guus A M S van Dongen; Otto Boerman
PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats.
Cancer biotherapy & radiopharmaceuticals 2004;19(2):155-63.
2004: Willy-Anne Nieuwlaat; Ad R M M Hermus; H Alec Ross; Wilhelmina C Buijs; Michela A Edelbroek; Jo W Bus; Frans H M Corstens; Dyde A Huysmans
Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(4):626-33.
2004: Adrienne H Brouwers; Julliëtte E M van Eerd; Cathelijne Frielink; Egbert Oosterwijk; Wim J G Oyen; Frans H M Corstens; Otto Boerman
Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(2):327-37.
2004: Chantal P Bleeker-Rovers; Otto Boerman; Huub J J M Rennen; Frans H M Corstens; Wim J G Oyen
Radiolabeled compounds in diagnosis of infectious and inflammatory disease.
Current pharmaceutical design 2004;10(24):2935-50.
2004: Wouter V Vogel; Wim J G Oyen; Jelle O Barentsz; Johannes H A M Kaanders; Frans H M Corstens
PET/CT: panacea, redundancy, or something in between?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45 Suppl 1():15S-24S.
2004: Julliëtte E M van Eerd; Peter Laverman; Wim J G Oyen; Thomas D Harris; D Scott Edwards; Charles E Ellars; Frans H M Corstens; Otto Boerman
Imaging of experimental colitis with a radiolabeled leukotriene B4 antagonist.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(1):89-93.
2004: Chantal P Bleeker-Rovers; S J H Bredie; Jos W M van der Meer; Frans H M Corstens; Wim J G Oyen
Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis.
The American journal of medicine 2004;116(1):50-3.
2004: Chantal P Bleeker-Rovers; Elisabeth M H A de Kleijn; Frans H M Corstens; Jos W M van der Meer; Wim J G Oyen
Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation.
European journal of nuclear medicine and molecular imaging 2004;31(1):29-37.
2003: Julliëtte E M van Eerd; Otto Boerman; Frans H M Corstens; Wim J G Oyen
Radiolabeled chemotactic cytokines: new agents for scintigraphic imaging of infection and inflammation.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 2003;47(4):246-55.
2003: Chantal P Bleeker-Rovers; S J H Bredie; J W M Van Der Meer; Frans H M Corstens; Wim J G Oyen
F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis.
The Netherlands journal of medicine 2003;61(10):323-9.
2003: M L Janssen; W Pels; L F A G Massuger; Wim J G Oyen; Henk Boonstra; Frans H M Corstens; Otto Boerman
Intraperitoneal radioimmunotherapy in an ovarian carcinoma mouse model: Effect of the radionuclide.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2003;13(5):607-13.
2003: Ernst J Postema; John M M Raemaekers; Wim J G Oyen; Otto Boerman; C M P W Mandigers; David M Goldenberg; Guus A M S van Dongen; Frans H M Corstens
Final results of a phase I radioimmunotherapy trial using (186)Re-epratuzumab for the treatment of patients with non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3995S-4002S.
2003: Adrienne H Brouwers; Wilhelmina C A M Buijs; Egbert Oosterwijk; Otto Boerman; Carola Mala; P H M De Mulder; Frans H M Corstens; Peter F A Mulders; Wim J G Oyen
Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with (131)I or (111)In: an intrapatient comparison.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3953S-60S.
2003: Frank G van Schaijk; Egbert Oosterwijk; Annemieke C Soede; Wim J G Oyen; William J McBride; Gary L Griffiths; David M Goldenberg; Frans H M Corstens; Otto Boerman
Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3880S-5S.
2003: Huub J J M Rennen; Otto Boerman; Wim J G Oyen; Frans H M Corstens
Kinetics of 99mTc-labeled interleukin-8 in experimental inflammation and infection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(9):1502-9.
2003: Adrienne H Brouwers; Cathelijne Frielink; Egbert Oosterwijk; Wim J G Oyen; Frans H M Corstens; Otto Boerman
Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma.
Cancer biotherapy & radiopharmaceuticals 2003;18(4):539-47.
2003: Ernst J Postema; Cathelijne Frielink; Wim J G Oyen; John M M Raemaekers; David M Goldenberg; Frans H M Corstens; Otto Boerman
Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphoma.
Cancer biotherapy & radiopharmaceuticals 2003;18(4):525-33.
2003: Dirk J de Jong; L Mannaerts; L G M Van Rossum; Frans H M Corstens; A H J Naber
Longitudinal study of bone mineral density in patients with Crohn's disease.
Digestive diseases and sciences 2003;48(7):1355-9.
2003: Julliëtte E M van Eerd; Wim J G Oyen; Thomas D Harris; Huub J J M Rennen; D Scott Edwards; Shuang Liu; Charles E Ellars; Frans H M Corstens; Otto Boerman
A bivalent leukotriene B(4) antagonist for scintigraphic imaging of infectious foci.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(7):1087-91.
2003: Willy-Anne Nieuwlaat; Dyde A Huysmans; Harrie C van den Bosch; C G J Sweep; H Alec Ross; Frans H M Corstens; Ad R M M Hermus
Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter.
The Journal of clinical endocrinology and metabolism 2003;88(7):3121-9.
2003: Frederieke M Brouwers; Wim J G Oyen; Otto Boerman; John A Barrett; Freek W A Verheugt; Frans H M Corstens; Jos W M van der Meer
Evaluation of Tc-99m-labeled glycoprotein IIb/IIIa receptor antagonist DMP444 SPECT in patients with infective endocarditis.
Clinical nuclear medicine 2003;28(6):480-4.
2003: Chantal P Bleeker-Rovers; Ruud G L de Sévaux; Henk W van Hamersvelt; Frans H M Corstens; Wim J G Oyen
Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(6):E18-21.
2003: Ernst J Postema; Wim J G Oyen; Otto Boerman; Frans H M Corstens
Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-labeled anti-CD20 monoclonal antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(5):853.
2003: Huub J J M Rennen; Wim J G Oyen; S A Cain; Peter N Monk; Frans H M Corstens; Otto Boerman
Tc-99m-labeled C5a and C5a des Arg74 for infection imaging.
Nuclear medicine and biology 2003;30(3):267-72.
2003: Otto Boerman; Frank G van Schaijk; Wim J G Oyen; Frans H M Corstens
Pretargeted radioimmunotherapy of cancer: progress step by step.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(3):400-11.
2002: Marcel Janssen; Wim J G Oyen; L F A G Massuger; Cathelijne Frielink; Ingrid Dijkgraaf; D Scott Edwards; Milind Radjopadhye; Frans H M Corstens; Otto Boerman
Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting.
Cancer biotherapy & radiopharmaceuticals 2002;17(6):641-6.
2002: Barbara S Langenhoff; Wim J G Oyen; GJ Jager; Simon P Strijk; Theo Wobbes; Frans H M Corstens; T J M Ruers
Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(22):4453-8.
2002: Marcel L Janssen; Wim J G Oyen; Ingrid Dijkgraaf; L F A G Massuger; Cathelijne Frielink; D Scott Edwards; Milind Rajopadhye; Henk Boonstra; Frans H M Corstens; Otto Boerman
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Cancer research 2002;62(21):6146-51.
2002: Jeroen M B Manders; Frans H M Corstens
Radioiodine therapy of euthyroid multinodular goitres.
European journal of nuclear medicine and molecular imaging 2002;29 Suppl 2():S466-70.
2002: Dirk J de Jong; Frans H M Corstens; L Mannaerts; L G M Van Rossum; A H J Naber
Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease?
The American journal of gastroenterology 2002;97(8):2011-5.
2002: Huub Rennen; Otto Boerman; Wim Oyen; Frans H M Corstens
Labeling method largely affects the imaging potential of interleukin-8.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(8):1128.
2002: Stefan Gratz; Huub J J M Rennen; Otto Boerman; Wim J G Oyen; Peter Mast; Thomas M Behr; Frans H M Corstens
99mTc-HMPAO-labeled autologous versus heterologous leukocytes for imaging infection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(7):918-24.
2002: Ruud G L de Sévaux; Andries J Hoitsma; Frans H M Corstens; Jack F M Wetzels
Treatment with vitamin D and calcium reduces bone loss after renal transplantation: a randomized study.
Journal of the American Society of Nephrology : JASN 2002;13(6):1608-14.
2002: Peter Laverman; Otto Boerman; Frans H M Corstens; Wim J G Oyen
Fluorinated amino acids for tumour imaging with positron emission tomography.
European journal of nuclear medicine and molecular imaging 2002;29(5):681-90.
2002: Huub J J M Rennen; Julliëtte E M van Eerd; Wim J G Oyen; Frans H M Corstens; D Scott Edwards; Otto Boerman
Effects of coligand variation on the in vivo characteristics of Tc-99m-labeled interleukin-8 in detection of infection.
Bioconjugate chemistry 2002;13(2):370-7.
2002: Adrienne H Brouwers; U Dorr; O Lang; Otto Boerman; Wim J G Oyen; M G Steffens; Egbert Oosterwijk; H G Mergenthaler; H Bihl; Frans H M Corstens
131 I-cG250 monoclonal antibody immunoscintigraphy versus [18 F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study.
Nuclear medicine communications 2002;23(3):229-36.
2002: Jeroen M B Manders; Ernst J Postema; Frans H M Corstens; Otto Boerman
Enhancing tumor implantation and growth rate of Ramos B-cell lymphoma in nude mice.
Comparative medicine 2002;52(1):36-8.
2002: T J M Ruers; Barbara S Langenhoff; N Neeleman; GJ Jager; Simon P Strijk; Theo Wobbes; Frans H M Corstens; Wim J G Oyen
Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(2):388-95.
2001: Ernst J Postema; Otto Boerman; Wim J G Oyen; John M M Raemaekers; Frans H M Corstens
Radioimmunotherapy of B-cell non-Hodgkin's lymphoma.
European journal of nuclear medicine 2001;28(11):1725-35.
2001: Willy-Anne Nieuwlaat; Ad R M M Hermus; F Sivro-Prndelj; Frans H M Corstens; Dyde A Huysmans
Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters.
The Journal of clinical endocrinology and metabolism 2001;86(11):5330-6.
2001: Wim J G Oyen; Otto Boerman; Frans H M Corstens
Animal models of infection and inflammation and their role in experimental nuclear medicine.
Journal of microbiological methods 2001;47(2):151-7.
2001: Otto Boerman; Huub J J M Rennen; Wim J G Oyen; Frans H M Corstens
Radiopharmaceuticals to image infection and inflammation.
Seminars in nuclear medicine 2001;31(4):286-95.
2001: Wim J G Oyen; J Alfred Witjes; Frans H M Corstens
Nuclear medicine techniques for the diagnosis and therapy of prostate carcinoma.
European urology 2001;40(3):294-9.
2001: Otto Boerman; J van Eerd; Wim J G Oyen; Frans H M Corstens
A 3-step pretargeting strategy to image infection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(9):1405-11.
2001: Peter Laverman; Els Th M Dams; Gert Storm; Theo Hafmans; Huib Croes; Wim J G Oyen; Frans H M Corstens; Otto Boerman
Microscopic localization of PEG-liposomes in a rat model of focal infection.
Journal of controlled release : official journal of the Controlled Release Society 2001;75(3):347-55.
2001: Stefan Gratz; Huub J J M Rennen; Otto Boerman; Wim J G Oyen; P Burma; Frans H M Corstens
(99m)Tc-interleukin-8 for imaging acute osteomyelitis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(8):1257-64.
2001: Otto Boerman; Wim J G Oyen; Frans H M Corstens
Progress in gene therapy: seeing is believing.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(8):1235-7.
2001: Peter Laverman; M G Carstens; Otto Boerman; Els Th M Dams; Wim J G Oyen; Nico van Rooijen; Frans H M Corstens; Gert Storm
Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection.
The Journal of pharmacology and experimental therapeutics 2001;298(2):607-12.
2001: Huub J J M Rennen; Frans H M Corstens; Wim J G Oyen; Otto Boerman
New concepts in infection/inflammation imaging.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 2001;45(2):167-73.
2001: Stefan Gratz; Huub J J M Rennen; Otto Boerman; Wim J G Oyen; Frans H M Corstens
Rapid imaging of experimental colitis with (99m)Tc-interleukin-8 in rabbits.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(6):917-23.
2001: Huub J J M Rennen; J Makarewicz; Wim J G Oyen; Peter Laverman; Frans H M Corstens; Otto Boerman
The effect of molecular weight on nonspecific accumulation of (99m)T-labeled proteins in inflammatory foci.
Nuclear medicine and biology 2001;28(4):401-8.
2001: Huub J J M Rennen; Otto Boerman; Wim J G Oyen; Frans H M Corstens
Imaging infection/inflammation in the new millennium.
European journal of nuclear medicine 2001;28(2):241-52.
2001: Otto Boerman; Els Th M Dams; Wim J G Oyen; Frans H M Corstens; Gert Storm
Radiopharmaceuticals for scintigraphic imaging of infection and inflammation.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2001;50(2):55-64.
2001: Huub J J M Rennen; Otto Boerman; Wim J G Oyen; Jos W M van der Meer; Frans H M Corstens
Specific and rapid scintigraphic detection of infection with 99mTc-labeled interleukin-8.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(1):117-23.
2000: Adrienne H Brouwers; Peter Laverman; Otto Boerman; Wim J G Oyen; John A Barrett; Thomas D Harris; D Scott Edwards; Frans H M Corstens
A 99Tcm-labelled leukotriene B4 receptor antagonist for scintigraphic detection of infection in rabbits.
Nuclear medicine communications 2000;21(11):1043-50.
2000: Otto Boerman; Peter Laverman; Wim J G Oyen; Frans H M Corstens; G Storm
Radiolabeled liposomes for scintigraphic imaging.
Progress in lipid research 2000;39(5):461-75.
2000: Huub J J M Rennen; Otto Boerman; E B Koenders; Wim J G Oyen; Frans H M Corstens
Labeling proteins with Tc-99m via hydrazinonicotinamide (HYNIC): optimization of the conjugation reaction.
Nuclear medicine and biology 2000;27(6):599-604.
2000: Pilar Barrera; CJ van der Laken; Otto Boerman; Wim J G Oyen; MT van de Ven; P L E M van Lent; L B van de Putte; Frans H M Corstens
Radiolabelled interleukin-1 receptor antagonist for detection of synovitis in patients with rheumatoid arthritis.
Rheumatology (Oxford, England) 2000;39(8):870-4.
2000: Otto Boerman; Wim J G Oyen; Frans H M Corstens
Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals.
Seminars in nuclear medicine 2000;30(3):195-208.
2000: Peter Laverman; Adrienne H Brouwers; Els Th M Dams; Wim J G Oyen; Gert Storm; Nico van Rooijen; Frans H M Corstens; Otto Boerman
Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose.
The Journal of pharmacology and experimental therapeutics 2000;293(3):996-1001.
2000: Peter Laverman; Samuel Zalipsky; Wim J G Oyen; Els Th M Dams; Gert Storm; Nasreen Mullah; Frans H M Corstens; Otto Boerman
Improved imaging of infections by avidin-induced clearance of 99mTc-biotin-PEG liposomes.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(5):912-8.
2000: Els Th M Dams; MW Nijhof; Otto Boerman; Peter Laverman; Gert Storm; Pieter Buma; J A Lemmens; Jos W M van der Meer; Frans H M Corstens; Wim J G Oyen
Scintigraphic evaluation of experimental chronic osteomyelitis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(5):896-902.
2000: Wim J G Oyen; Otto Boerman; Frederieke M Brouwers; John A Barrett; Freek W A Verheugt; D J Ruiter; Frans H M Corstens; Jos W M van der Meer
Scintigraphic detection of acute experimental endocarditis with the technetium-99m labelled glycoprotein IIb/IIIa receptor antagonist DMP444.
European journal of nuclear medicine 2000;27(4):392-9.
2000: Els Th M Dams; Wim J G Oyen; Otto Boerman; Gert Storm; Peter Laverman; P J Kok; Wilhelmina C A M Buijs; H Bakker; Jos W M van der Meer; Frans H M Corstens
99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(4):622-30.
2000: CJ van der Laken; Otto Boerman; Wim J G Oyen; MT van de Ven; Jos W M van der Meer; Frans H M Corstens
Radiolabeled interleukin-8: specific scintigraphic detection of infection within a few hours.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(3):463-9.
2000: Els Th M Dams; Peter Laverman; Wim J G Oyen; Gert Storm; G L Scherphof; Jos W M van der Meer; Frans H M Corstens; Otto Boerman
Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.
The Journal of pharmacology and experimental therapeutics 2000;292(3):1071-9.
2000: Adrienne H Brouwers; Dirk J de Jong; Els Th M Dams; Wim J G Oyen; Otto Boerman; Peter Laverman; Ton H J Naber; Gert Storm; Frans H M Corstens
Tc-99m-PEG-Liposomes for the evaluation of colitis in Crohn's disease.
Journal of drug targeting 2000;8(4):225-33.
1999: Els Th M Dams; Martin J Becker; Wim J G Oyen; Otto Boerman; Gert Storm; Peter Laverman; Siem de Marie; J W van der Meer; Irma A J M Bakker-Woudenberg; Frans H M Corstens
Scintigraphic imaging of bacterial and fungal infection in granulocytopenic rats.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(12):2066-72.
1999: MG Steffens; Otto Boerman; P H M De Mulder; Wim J G Oyen; Wilhelmina C A M Buijs; J Alfred Witjes; Wim J M van den Broek; Jeannette C Oosterwijk-Wakka; Frans M J Debruyne; Frans H M Corstens; Egbert Oosterwijk
Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3268s-3274s.
1999: Otto Boerman; MH Kranenborg; Egbert Oosterwijk; G L Griffiths; W J McBride; Wim J G Oyen; Mirjam de Weijert; Jeannette C Oosterwijk-Wakka; H J Hansen; Frans H M Corstens
Pretargeting of renal cell carcinoma: improved tumor targeting with a bivalent chelate.
Cancer research 1999;59(17):4400-5.
1999: Frans H M Corstens; Jos W M van der Meer
Nuclear medicine's role in infection and inflammation.
Lancet 1999;354(9180):765-70.
1999: MG Steffens; Egbert Oosterwijk; MH Kranenborg; J M Manders; Frans M J Debruyne; Frans H M Corstens; Otto Boerman
In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(5):829-36.
1999: Els Th M Dams; michel reijnen; Wim J G Oyen; Otto Boerman; Peter Laverman; Gert Storm; Jos W M van der Meer; Frans H M Corstens; H van Goor
Imaging experimental intraabdominal abscesses with 99mTc-PEG liposomes and 99mTc-HYNIC IgG.
Annals of surgery 1999;229(4):551-7.
1999: MG Steffens; Otto Boerman; Wim J G Oyen; P H Kniest; J Alfred Witjes; GO Oosterhof; Geert J L H van Leenders; Frans M J Debruyne; Frans H M Corstens; Egbert Oosterwijk
Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: implications for fractionated dose radioimmunotherapy.
Cancer research 1999;59(7):1615-9.
1999: MG Steffens; Jeannette C Oosterwijk-Wakka; NE Zegwaart-Hagemeier; Otto Boerman; Frans M J Debruyne; Frans H M Corstens; Egbert Oosterwijk
Immunohistochemical analysis of tumor antigen saturation following injection of monoclonal antibody G250.
Anticancer research 1999;19(2A):1197-200.
1999: Peter Laverman; Els Th M Dams; Wim J G Oyen; Gert Storm; EB Koenders; R Prevost; Jos W M van der Meer; Frans H M Corstens; Otto Boerman
A novel method to label liposomes with 99mTc by the hydrazino nicotinyl derivative.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(1):192-7.
1998: Otto Boerman; Wim J G Oyen; Frans H M Corstens; Gert Storm
Liposomes for scintigraphic imaging: optimization of in vivo behavior.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1998;42(4):271-9.
1998: Els Th M Dams; Wim J G Oyen; Otto Boerman; Gert Storm; Peter Laverman; EB Koenders; Jos W M van der Meer; Frans H M Corstens
Technetium-99m-labeled liposomes to image experimental colitis in rabbits: comparison with technetium-99m-HMPAO-granulocytes and technetium-99m-HYNIC-IgG.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(12):2172-8.
1998: Wilhelmina C A M Buijs; J A Siegel; Otto Boerman; Frans H M Corstens
Absolute organ activity estimated by five different methods of background correction.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(12):2167-72.
1998: MG Steffens; Egbert Oosterwijk; NE Zegwaart-Hagemeier; M A van't Hof; Frans M J Debruyne; Frans H M Corstens; Otto Boerman
Immunohistochemical analysis of intratumoral heterogeneity of [131I]cG250 antibody uptake in primary renal cell carcinomas.
British journal of cancer 1998;78(9):1208-13.
1998: Wilhelmina C A M Buijs; J G Tibben; Otto Boerman; C F Molthoff; L F Massuger; EB Koenders; C P T Schijf; J A Siegel; Frans H M Corstens
Dosimetric analysis of chimeric monoclonal antibody cMOv18 IgG in ovarian carcinoma patients after intraperitoneal and intravenous administration.
European journal of nuclear medicine 1998;25(11):1552-61.
1998: Wilhelmina C A M Buijs; Wim J G Oyen; Els Th M Dams; Otto Boerman; J A Siegel; RA Claessens; Jos W M van der Meer; Frans H M Corstens
Dynamic distribution and dosimetric evaluation of human non-specific immunoglobulin G labelled with 111In or 99Tcm.
Nuclear medicine communications 1998;19(8):743-51.
1998: CJ van der Laken; Otto Boerman; Wim J G Oyen; Peter Laverman; MT van de Ven; Frans H M Corstens; Jos W M van der Meer
In vivo expression of interleukin-1 receptors during various experimentally induced inflammatory conditions.
The Journal of infectious diseases 1998;177(5):1398-401.
1998: CJ van der Laken; Otto Boerman; Wim J G Oyen; MT van de Ven; Jos W M van der Meer; Frans H M Corstens
Scintigraphic detection of infection and inflammation: new developments with special emphasis on receptor interaction.
European journal of nuclear medicine 1998;25(5):535-46.
1998: MG Steffens; MH Kranenborg; Otto Boerman; NE Zegwaart-Hagemeier; Frans M J Debruyne; Frans H M Corstens; Egbert Oosterwijk
Tumor retention of 186Re-MAG3, 111In-DTPA and 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts.
Cancer biotherapy & radiopharmaceuticals 1998;13(2):133-9.
1998: CJ van der Laken; Otto Boerman; Wim J G Oyen; MT van de Ven; Jos W M van der Meer; Frans H M Corstens
Imaging of infection in rabbits with radioiodinated interleukin-1 (alpha and beta), its receptor antagonist and a chemotactic peptide: a comparative study.
European journal of nuclear medicine 1998;25(4):347-52.
1998: CJ van der Laken; Otto Boerman; Wim J G Oyen; MT van de Ven; J W Ven der Meer; Frans H M Corstens
The kinetics of radiolabelled interleukin-8 in infection and sterile inflammation.
Nuclear medicine communications 1998;19(3):271-81.
1998: MH Kranenborg; Otto Boerman; Jeannette C Oosterwijk-Wakka; Mirjam de Weijert; Frans H M Corstens; Egbert Oosterwijk
Two-step radio-immunotargeting of renal-cell carcinoma xenografts in nude mice with anti-renal-cell-carcinoma X anti-DTPA bispecific monoclonal antibodies.
International journal of cancer. Journal international du cancer 1998;75(1):74-80.
1998: Els Th M Dams; Wim J G Oyen; Otto Boerman; RA Claessens; A B Wymenga; Jos W M van der Meer; Frans H M Corstens
Technetium-99m labeled to human immunoglobulin G through the nicotinyl hydrazine derivative: a clinical study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(1):119-24.
1998: Wim J G Oyen; J M Raemaekers; Frans H M Corstens
Acute myelofibrosis mimicking multiple bone metastases on Tc-99m MDP bone imaging.
Clinical nuclear medicine 1998;23(1):1-2.
1997: MH Kranenborg; Otto Boerman; Mirjam de Weijert; Jeannette C Oosterwijk-Wakka; Frans H M Corstens; Egbert Oosterwijk
The effect of antibody protein dose of anti-renal cell carcinoma monoclonal antibodies in nude mice with renal cell carcinoma xenografts.
Cancer 1997;80(12 Suppl):2390-7.
1997: CJ van der Laken; Otto Boerman; Wim J G Oyen; MT van de Ven; R Chizzonite; Frans H M Corstens; Jos W M van der Meer
Preferential localization of systemically administered radiolabeled interleukin 1alpha in experimental inflammation in mice by binding to the type II receptor.
The Journal of clinical investigation 1997;100(12):2970-6.
1997: F H van den Hoogen; Wilhelmina C A M Buijs; AM Boerbooms; L B van de Putte; Frans H M Corstens
Quantitative esophageal scintigraphy: how reproducible is this test?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(10):1665.
1997: Wim J G Oyen; Otto Boerman; Els Th M Dams; Gert Storm; L van Bloois; EB Koenders; U J van Haelst; Jos W M van der Meer; Frans H M Corstens
Scintigraphic evaluation of experimental colitis in rabbits.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(10):1596-600.
1997: MW Nijhof; Wim J G Oyen; A van Kampen; RA Claessens; Jos W M van der Meer; Frans H M Corstens
Hip and knee arthroplasty infection. In-111-IgG scintigraphy in 102 cases.
Acta orthopaedica Scandinavica 1997;68(4):332-6.
1997: CJ van der Laken; Otto Boerman; Wim J G Oyen; MT van de Ven; D Scott Edwards; John A Barrett; Jos W M van der Meer; Frans H M Corstens
Technetium-99m-labeled chemotactic peptides in acute infection and sterile inflammation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(8):1310-5.
1997: MW Nijhof; Wim J G Oyen; A van Kampen; RA Claessens; Jos W M van der Meer; Frans H M Corstens
Evaluation of infections of the locomotor system with indium-111-labeled human IgG scintigraphy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(8):1300-5.
1997: Otto Boerman; Wim J G Oyen; Gert Storm; Maria Luísa Corvo; L van Bloois; Jos W M van der Meer; Frans H M Corstens
Technetium-99m labelled liposomes to image experimental arthritis.
Annals of the rheumatic diseases 1997;56(6):369-73.
1997: MH Kranenborg; Wim J G Oyen; Frans H M Corstens; Egbert Oosterwijk; Jos W M van der Meer; Otto Boerman
Rapid imaging of experimental infection with technetium-99m-DTPA after anti-DTPA monoclonal antibody priming.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(6):901-6.
1997: MG Steffens; Otto Boerman; Jeannette C Oosterwijk-Wakka; GO Oosterhof; J Alfred Witjes; EB Koenders; Wim J G Oyen; Wilhelmina C A M Buijs; Frans M J Debruyne; Frans H M Corstens; Egbert Oosterwijk
Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1529-37.
1997: D Huysmans; A Hermus; M Edelbroek; J Barentsz; Frans H M Corstens; P Kloppenborg
Radioiodine for nontoxic multinodular goiter.
Thyroid : official journal of the American Thyroid Association 1997;7(2):235-9.
1997: Otto Boerman; Wim J G Oyen; L van Bloois; EB Koenders; Jos W M van der Meer; Frans H M Corstens; Gert Storm
Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(3):489-93.
1996: R M Perenboom; P Beckers; Jos W M van der Meer; A C Van Schijndel; Wim J G Oyen; Frans H M Corstens; Robert W Sauerwein
Pro-inflammatory cytokines in lung and blood during steroid-induced Pneumocystis carinii pneumonia in rats.
Journal of leukocyte biology 1996;60(6):710-5.
1996: D A Huysmans; Wilhelmina C A M Buijs; MT van de Ven; W J van den Broek; P W Kloppenborg; Ad R M M Hermus; Frans H M Corstens
Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(12):2072-9.
1996: RA Claessens; EB Koenders; Wim J G Oyen; Frans H M Corstens
Retention of technetium-99m in infectious foci in rats after release from technetium-99m labelled human non-specific polyclonal immunoglobulin G: a dual-label study with hydrazinonicotinamido and iminothiolano immunoglobulin.
European journal of nuclear medicine 1996;23(11):1536-9.
1996: CJ van der Laken; Otto Boerman; Wim J G Oyen; MT van de Ven; RA Claessens; Jos W M van der Meer; Frans H M Corstens
Different behaviour of radioiodinated human recombinant interleukin-1 and its receptor antagonist in an animal model of infection.
European journal of nuclear medicine 1996;23(11):1531-5.
1996: Wim J G Oyen; Otto Boerman; Gert Storm; L van Bloois; EB Koenders; Daan J A Crommelin; Jos W M van der Meer; Frans H M Corstens
Labelled Stealth liposomes in experimental infection: an alternative to leukocyte scintigraphy?
Nuclear medicine communications 1996;17(9):742-8.
1996: Wim J G Oyen; Otto Boerman; Gert Storm; L van Bloois; EB Koenders; RA Claessens; R M Perenboom; Daan J A Crommelin; Jos W M van der Meer; Frans H M Corstens
Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(8):1392-7.
1996: Wim J G Oyen; Otto Boerman; R Subramanian; EB Koenders; RA Claessens; Jos W M van der Meer; Frans H M Corstens
Biodistribution of 111In-labelled IgG and IgM in experimental infection.
Nuclear medicine communications 1996;17(7):616-20.
1996: Wim J G Oyen; Otto Boerman; CJ van der Laken; Jos W M van der Meer; Frans H M Corstens
Macrophage targeting in experimental arthritis.
European journal of nuclear medicine 1996;23(6):727-9.
1996: J G Tibben; Otto Boerman; L F A G Massuger; C P T Schijf; RA Claessens; Frans H M Corstens
Pharmacokinetics, biodistribution and biological effects of intravenously administered bispecific monoclonal antibody OC/TR F(ab')2 in ovarian carcinoma patients.
International journal of cancer. Journal international du cancer 1996;66(4):477-83.
1996: Wim J G Oyen; Otto Boerman; CJ van der Laken; RA Claessens; Jos W M van der Meer; Frans H M Corstens
The uptake mechanisms of inflammation- and infection-localizing agents.
European journal of nuclear medicine 1996;23(4):459-65.
1996: RA Claessens; Otto Boerman; EB Koenders; Wim J G Oyen; Jos W M van der Meer; Frans H M Corstens
Technetium-99m labelled hydrazinonicotinamido human non-specific polyclonal immunoglobulin G for detection of infectious foci: a comparison with two other technetium-labelled immunoglobulin preparations.
European journal of nuclear medicine 1996;23(4):414-21.
1996: Frans H M Corstens
Highlights of the annual meeting of the European Association of Nuclear Medicine: Brussels 1995. The art of imaging the body.
European journal of nuclear medicine 1996;23(1):75-90.
1996: Wim J G Oyen; J Albert M Lemmens; RA Claessens; Jim R Van Horn; Tom J J H Slooff; Frans H M Corstens
Nuclear arthrography: combined scintigraphic and radiographic procedure for diagnosis of total hip prosthesis loosening.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(1):62-70.
1995: MH Kranenborg; Otto Boerman; Jeannette C Oosterwijk-Wakka; Mirjam de Weijert; Frans H M Corstens; Egbert Oosterwijk
Development and characterization of anti-renal cell carcinoma x antichelate bispecific monoclonal antibodies for two-phase targeting of renal cell carcinoma.
Cancer research 1995;55(23 Suppl):5864s-5867s.
1995: CJ van der Laken; Otto Boerman; Wim J G Oyen; MT van de Ven; RA Claessens; Jos W M van der Meer; Frans H M Corstens
Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental model.
European journal of nuclear medicine 1995;22(11):1249-55.
1995: Wim J G Oyen; A M van Oort; R B Tanke; G J van Mill; W R Aengevaeren; Frans H M Corstens
Pulmonary perfusion after endovascular stenting of pulmonary artery stenosis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(11):2006-8.
1995: E M de Kleijn; W J Oyen; R A Claessens; Frans H M Corstens; Jos W M van der Meer
Utility of scintigraphic methods in patients with fever of unknown origin.
Archives of internal medicine 1995;155(18):1989-94.
1995: J G Tibben; Chris M G Thomas; L F A G Massuger; M F Segers; C P T Schijf; Frans H M Corstens; Otto Boerman
Humoral anti-OV-TL 3 response after the intravenous administration of radiolabelled Fab' or F(ab')2 fragments in ovarian cancer patients.
Nuclear medicine communications 1995;16(10):853-9.
1995: R M Perenboom; Wim J G Oyen; A C van Schijndel; P Beckers; Frans H M Corstens; Jos W M van der Meer
Serial indium-111-labelled IgG biodistribution in rat Pneumocystis carinii pneumonia: a tool to monitor the course and severity of the infection.
European journal of nuclear medicine 1995;22(10):1129-32.
1995: Ad R M M Hermus; AG Smals; LM Swinkels; D A Huysmans; G F Pieters; C F Sweep; Frans H M Corstens; P W Kloppenborg
Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
The Journal of clinical endocrinology and metabolism 1995;80(10):2859-65.
1995: Otto Boerman; J G Tibben; L F A G Massuger; RA Claessens; Frans H M Corstens
Tumour targeting of the anti-ovarian carcinoma x anti-CD3/TCR bispesific monoclonal antibody OC/TR and its parental MOv18 antibody in experimental ovarian cancer.
Anticancer research 1995;15(5B):2169-74.
1995: Otto Boerman; Gert Storm; Wim J G Oyen; L van Bloois; Jos W M van der Meer; RA Claessens; Daan J A Crommelin; Frans H M Corstens
Sterically stabilized liposomes labeled with indium-111 to image focal infection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(9):1639-44.
1995: Wim J G Oyen; Frans H M Corstens
Scintigraphic techniques for delineation of infection and inflammation.
British journal of hospital medicine 1995;54(2-3):75-80.
1995: D A Huysmans; Ad R M M Hermus; AG Smals; Frans H M Corstens; P W Kloppenborg
[Treatment of hyperthyroidism and indications for radioactive iodine].
Nederlands tijdschrift voor geneeskunde 1995;139(24):1251-2.
1995: Wim J G Oyen; A H Mudde; W J van den Broek; Frans H M Corstens
Metastatic follicular carcinoma of the thyroid: reappearance of radioiodine uptake.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(4):613-5.
1995: RA Claessens; EB Koenders; Otto Boerman; Wim J G Oyen; G F Borm; Jos W M van der Meer; Frans H M Corstens
Dissociation of indium from indium-111-labelled diethylene triamine penta-acetic acid conjugated non-specific polyclonal human immunoglobulin G in inflammatory foci.
European journal of nuclear medicine 1995;22(3):212-9.
1994: D A Huysmans; Ad R M M Hermus; Frans H M Corstens; J O Barentsz; P W Kloppenborg
Large, compressive goiters treated with radioiodine.
Annals of internal medicine 1994;121(10):757-62.
1994: J G Tibben; L F A G Massuger; Otto Boerman; G F Borm; RA Claessens; Frans H M Corstens
Effect of the route of administration on the biodistribution of radioiodinated OV-TL 3 F(ab')2 in experimental ovarian cancer.
European journal of nuclear medicine 1994;21(11):1183-90.
1994: D A Huysmans; M M de Haas; W J van den Broek; Ad R M M Hermus; J O Barentsz; Frans H M Corstens; SH Ruijs
Magnetic resonance imaging for volume estimation of large multinodular goitres: a comparison with scintigraphy.
The British journal of radiology 1994;67(798):519-23.
1994: Ad R M M Hermus; D A Huysmans; AG Smals; Frans H M Corstens; P W Kloppenborg
Remarkable improvement of osteopenia after cure of Cushing's syndrome.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1994;26(4):209-10.
1994: Wim J G Oyen; Otto Boerman; RA Claessens; Jos W M van der Meer; Frans H M Corstens
Is somatostatin receptor scintigraphy suited to detection of acute infectious disease?
Nuclear medicine communications 1994;15(4):289-93.
1994: J G Tibben; L F A G Massuger; Otto Boerman; RA Claessens; G F Borm; Koon Pak; EB Koenders; Frans H M Corstens
Decreased kidney uptake of technetium-99m-labelled Fab' fragments in ovarian carcinoma bearing nude mice using a cleavable chelator.
Nuclear medicine and biology 1994;21(1):17-24.
1993: Wim J G Oyen; I E Arntz; R M Claessens; Jos W M van der Meer; Frans H M Corstens; R J Goris
Reflex sympathetic dystrophy of the hand: an excessive inflammatory response?
Pain 1993;55(2):151-7.
1993: D A Huysmans; Ad R M M Hermus; Frans H M Corstens; P W Kloppenborg
Long-term results of two schedules of radioiodine treatment for toxic multinodular goitre.
European journal of nuclear medicine 1993;20(11):1056-62.
1993: Pierre N M Demacker; T P Dormans; E B Koenders; Frans H M Corstens
Evaluation of indium-111-polyclonal immunoglobulin G to quantitate atherosclerosis in Watanabe heritable hyperlipidemic rabbits with scintigraphy: effect of age and treatment with antioxidants or ethinylestradiol.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(8):1316-21.
1993: J G Tibben; Otto Boerman; RA Claessens; Frans H M Corstens; M van Deuren; P H de Mulder; J W van der Meer; K G Keijser; L F A G Massuger
Cytokine release in an ovarian carcinoma patient following intravenous administration of bispecific antibody OC/TR F(ab')2.
Journal of the National Cancer Institute 1993;85(12):1003-4.
1993: Frans H M Corstens; Wim J G Oyen; W S Becker
Radioimmunoconjugates in the detection of infection and inflammation.
Seminars in nuclear medicine 1993;23(2):148-64.
1993: F G Corten; Martin A van 't Hof; Wilhelmina C A M Buijs; P Hoppenbrouwers; Warner Kalk; Frans H M Corstens
Measurement of mandibular bone density ex vivo and in vivo by dual-energy X-ray absorptiometry.
Archives of oral biology 1993;38(3):215-9.
1993: Wim J G Oyen; Wilhelmina C A M Buijs; A van Kampen; EB Koenders; RA Claessens; Frans H M Corstens
Intraoperative bone and bone marrow sampling: a simple method for accurate measurement of uptake of radiopharmaceuticals in bone and bone marrow.
Nuclear medicine communications 1993;14(2):112-6.
1993: R F J M Laan; Wilhelmina C A M Buijs; André L M Verbeek; M P Draad; Frans H M Corstens; L B A Van De Putte; P L C M van Riel
Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity.
Annals of the rheumatic diseases 1993;52(1):21-6.
1992: J G Tibben; L F A G Massuger; RA Claessens; C P T Schijf; Koon Pak; S P Strijk; Peter Kenemans; Frans H M Corstens
Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancer.
Nuclear medicine communications 1992;13(12):885-93.
1992: L F A G Massuger; Chris M G Thomas; M F Segers; Frans H M Corstens; René H M Verheijen; Peter Kenemans; Lambert G Poels
Specific and nonspecific immunoassays to detect HAMA after administration of indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody to patients with ovarian cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(11):1958-63.
1992: Wim J G Oyen; PM Netten; J Albert M Lemmens; RA Claessens; J A Lutterman; J A van der Vliet; R J Goris; Jos W M van der Meer; Frans H M Corstens
Evaluation of infectious diabetic foot complications with indium-111-labeled human nonspecific immunoglobulin G.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(7):1330-6.
1992: Wilhelmina C A M Buijs; L F A G Massuger; RA Claessens; Peter Kenemans; Frans H M Corstens
Dosimetric evaluation of immunoscintigraphy using indium-111-labeled monoclonal antibody fragments in patients with ovarian cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(6):1113-20.
1992: Wim J G Oyen; RA Claessens; Jos W M van der Meer; Robert Rubin; Harry W Strauss; Frans H M Corstens
Indium-111-labeled human nonspecific immunoglobulin G: a new radiopharmaceutical for imaging infectious and inflammatory foci.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;14(5):1110-8.
1992: Wim J G Oyen; RA Claessens; Jos W M van der Meer; Frans H M Corstens
Biodistribution and kinetics of radiolabeled proteins in rats with focal infection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(3):388-94.
1992: Wim J G Oyen; RA Claessens; J M Raemaekers; B E de Pauw; Jos W M van der Meer; Frans H M Corstens
Diagnosing infection in febrile granulocytopenic patients with indium-111-labeled human immunoglobulin G.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(1):61-8.
1992: Wim J G Oyen; Jim R Van Horn; RA Claessens; Tom J J H Slooff; Jos W M van der Meer; Frans H M Corstens
Diagnosis of bone, joint, and joint prosthesis infections with In-111-labeled nonspecific human immunoglobulin G scintigraphy.
Radiology 1992;182(1):195-9.
1991: L F A G Massuger; Otto Boerman; Frans H M Corstens; René H M Verheijen; RA Claessens; Lambert G Poels; W J van den Broek; Peter Kenemans
Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic mice.
Anticancer research 1991;11(6):2051-7.
1991: Wim J G Oyen; RA Claessens; Jos W M van der Meer; Frans H M Corstens
Detection of subacute infectious foci with indium-111-labeled autologous leukocytes and indium-111-labeled human nonspecific immunoglobulin G: a prospective comparative study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(10):1854-60.
1991: L F A G Massuger; Peter Kenemans; RA Claessens; René H M Verheijen; Frans H M Corstens
Detection and localization of ovarian cancer with radiolabeled monoclonal antibodies.
European journal of obstetrics, gynecology, and reproductive biology 1991;41(1):47-63.
1991: Paul Smits; Frans H M Corstens; Wim R M Aengevaeren; F J Wackers; Theo Thien
False-negative dipyridamole-thallium-201 myocardial imaging after caffeine infusion.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(8):1538-41.
1991: L F A G Massuger; RA Claessens; Peter Kenemans; René H M Verheijen; Otto Boerman; A P Meeuwis; C P T Schijf; Wilhelmina C A M Buijs; T G Hanselaar; Frans H M Corstens
Kinetics and biodistribution in relation to tumour detection with 111In-labelled OV-TL 3 F(ab')2 in patients with ovarian cancer.
Nuclear medicine communications 1991;12(7):593-609.
1991: D A Huysmans; Frans H M Corstens; P W Kloppenborg
Long-term follow-up in toxic solitary autonomous thyroid nodules treated with radioactive iodine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(1):27-30.
1991: L F A G Massuger; RA Claessens; Koon Pak; Otto Boerman; P E Daddona; EB Koenders; Peter Kenemans; Frans H M Corstens
Tissue distribution of 99mTc, 111In and 123I-OV-TL 3 Fab' in ovarian carcinoma bearing nude mice.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(1):77-83.
1990: L F A G Massuger; Peter Kenemans; RA Claessens; René H M Verheijen; C P T Schijf; S P Strijk; Lambert G Poels; R G van Hoesel; Frans H M Corstens
Immunoscintigraphy of ovarian cancer with indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(11):1802-10.
1990: L F A G Massuger; R Claessens; Peter Kenemans; T Hanselaar; Frans H M Corstens
Nonantigen-specific tissue localization of monoclonal antibodies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(8):1438.
1990: Wim J G Oyen; RA Claessens; J R van Horn; Jos W M van der Meer; Frans H M Corstens
Scintigraphic detection of bone and joint infections with indium-111-labeled nonspecific polyclonal human immunoglobulin G.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(4):403-12.
1989: A A M Masclee; W P M Hopman; Frans H M Corstens; G Rosenbusch; J B M J Jansen; Cornelis B H W Lamers
Simultaneous measurement of gallbladder emptying with cholescintigraphy and US during infusion of physiologic doses of cholecystokinin: a comparison.
Radiology 1989;173(2):407-10.
1989: Paul Smits; Wim R M Aengevaeren; Frans H M Corstens; Theo Thien
Caffeine reduces dipyridamole-induced myocardial ischemia.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(10):1723-6.
1989: A A M Masclee; J B M J Jansen; Frans H M Corstens; Cornelis B H W Lamers
Reversible gall bladder dysfunction in severe pancreatic insufficiency.
Gut 1989;30(6):866-72.
1988: Frans H M Corstens; D Huysmans; P Kloppenborg
Thallium-201 scintigraphy of the suppressed thyroid: an alternative for iodine-123 scanning after TSH stimulation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1988;29(8):1360-3.
1988: P L Van Valenberg; Frans H M Corstens
Hunter's shoulder in bone imaging.
Clinical nuclear medicine 1988;13(1):62.
1988: L B Beentjes; Wilhelmina C A M Buijs; Frans H M Corstens; J H Duijsings
Radioactive contamination of Kiev vacationers after the Chernobyl accident. Biological half-life of Cs.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1988;15(2):171-5.